Treating Refractory Schizophrenia With rTMS
Effect of rTMS Over the Medial Cerebellum on Negative Symptoms and Cognitive Dysmetria in Subjects With Treatment Refractory Schizophrenia
Sponsor: Abbott Medical Devices
Terminated
IRB approval expired and study ceased.
Other terminated trials from Abbott Medical Devices
Other Schizophrenia trials with similar outcome
This NA trial investigates Schizophrenia and is currently terminated or withdrawn. Abbott Medical Devices leads this study, which shows 12 recorded versions since 2011 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Dec 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 7 earlier versions
-
May 2021 — Dec 2021 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Jan 2021 — May 2021 [monthly]
Unknown Status NA
-
Nov 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Feb 2019 — Nov 2019 [monthly]
Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- Seton Healthcare Family
- University of Texas at Austin
For direct contact, visit the study record on ClinicalTrials.gov .